A Phase Ib Study Evaluating the Recommended Phase II Dose, Safety, Tolerability, and Efficacy of Mivavotinib in Combination with Nivolumab in Advanced Solid Tumors.Dejan Juric,Minal Barve,Ulka Vaishampayan,Desamparados Roda,Aitana Calvo,Noelia Martinez Janez,Jose Trigo,Alastair Greystoke,R. Donald Harvey,Anthony J. Olszanski,Mateusz Opyrchal,Alexander Spira,Fiona Thistlethwaite, Begona Jimenez,Jessica Huck Sappal,Karuppiah Kannan, Jason Riley,Cheryl Li,Cong Li,Richard C. Gregory,Harry Miao,Shining WangCANCER MEDICINE(2024)引用 1|浏览32关键词immunotherapy,mivavotinib,phase Ib,solid tumors,TNBCAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要